NEXT-GEN
Global Top 25 Genomic Revolution Analysis
The LAPIS Global Top 25 Genomic Revolution Analysis is composed of 25 worldwide best-known and leading companies in the genomic sector. All companies are equally weighted.
Analysis facts
Transparent rules and disciplined signals that guide allocation through changing markets.
Asset class
EquityRegion
NEXT-GENCurrency
USDLaunch Date
01/01/2018Rebalancing
Semi-annually: end of April and OctoberCalculation
DailyNAV
261.07As of
30/10/2026Chart performance
Jan 1, 2025
Jan 1, 2026
201820192020202120222023202420252026
300250200150100500
JanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
LAPISBenchmark
Performance
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | YTD | 1 Yr | 3 Yr avg | since inception avg | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAPIS | 0.00% | 0.00% | -1.65% | 33.99% | 47.71% | 19.82% | -23.61% | -10.84% | 0.61% | 18.75% | 37.56% | 44.21% | 24.21% | 11.47% |
| Benchmark | 0.00% | 0.00% | -8.15% | 30.42% | 43.15% | 2.64% | -30.66% | -5.56% | -1.35% | 18.48% | 30.19% | 33.99% | 21.72% | 6.56% |
Constituents
Country breakdown
- Country
- USA72.00%
- China12.00%
- Switzerland12.00%
- Netherlands4.00%
Sector breakdown
- Sector
- Health Care100.00%